Jacob E. Tallman

Jacob E. Tallman

Urology

5758 S. Maryland Ave.
Chicago, IL 60637

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Editorial Comment on "Private Equity Acquisition Effect on the Most Common Urologic Procedures".

Editorial Comment on "Private Equity Acquisition Effect on the Most Common Urologic Procedures".

Journal: Urology

Published: August 17, 2026

Management of High-Risk Non-Muscle-Invasive Bladder Cancer.

Management of High-Risk Non-Muscle-Invasive Bladder Cancer.

Journal: The Urologic clinics of North America

Published: June 26, 2026

Editorial Comment on: "Frailty and Quality of Life in Low-Income, Uninsured Men With Prostate Cancer".

Editorial Comment on: "Frailty and Quality of Life in Low-Income, Uninsured Men With Prostate Cancer".

Journal: Urology

Published: June 02, 2026

Management of Intravesical Therapy-Related Lower Urinary Tract Symptoms-Leveraging Existing Options to Improve Outcomes.

Management of Intravesical Therapy-Related Lower Urinary Tract Symptoms-Leveraging Existing Options to Improve Outcomes.

Journal: The Journal of urology

Published: March 20, 2026

Editorial Comment on "Patient-reported Psychological and Prostate Cancer-specific Functional Outcomes Among Men With Low-risk Prostate Cancer Two Years After Diagnosis: The PREPARE Prospective Cohort Study".

Editorial Comment on "Patient-reported Psychological and Prostate Cancer-specific Functional Outcomes Among Men With Low-risk Prostate Cancer Two Years After Diagnosis: The PREPARE Prospective Cohort Study".

Journal: Urology

Published: March 18, 2026

Editorial Comment on "Patient-Reported Psychological and Prostate Cancer-Specific Functional Outcomes Among Men With Low-Risk Prostate Cancer Two Years After Diagnosis: The PREPARE Prospective Cohort Study".

Editorial Comment on "Patient-Reported Psychological and Prostate Cancer-Specific Functional Outcomes Among Men With Low-Risk Prostate Cancer Two Years After Diagnosis: The PREPARE Prospective Cohort Study".

Journal: Urology

Published: March 18, 2026

Robotic versus open post-chemotherapy retroperitoneal lymph node dissection: a propensity score matched study across 11 academic medical centers.

Robotic versus open post-chemotherapy retroperitoneal lymph node dissection: a propensity score matched study across 11 academic medical centers.

Journal: World journal of urology

Published: February 10, 2026

Reply: Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit.

Reply: Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit.

Journal: The Journal of urology

Published: May 28, 2025

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

Journal: The Journal of experimental medicine

Published: April 01, 2025

Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract.

Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: January 14, 2025

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: January 13, 2025

Toward Improved Prostate Cancer Screening: Insights from the Göteborg-2 Trial.

Toward Improved Prostate Cancer Screening: Insights from the Göteborg-2 Trial.

Journal: Clinical chemistry

Published: January 05, 2025

Showing 1-12 of 35

Last Updated: 09/26/2026